PRAVASTATIN
PROICM 2019-02 PRA
Phase 2 small_molecule active
Quick answer
PRAVASTATIN for Patients with severe and radio-induced breast fibrosis after breast cancer is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Patients with severe and radio-induced breast fibrosis after breast cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active